RAP's 3rd product with massive market after acute respiratory diagnosis and chronic respiratory management for Asthma and COPD for all age demographic (except COPD will only be for adult).
Ann: ResApp announces positive results of COVID-19 screening test, page-195
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #